Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 212

Related Articles by Review for PubMed (Select 17603079)

1.

Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: roles of Fas, Apaf-1, NFkappaB, IAPs, Smac/DIABLO, and AIF.

Huerta S, Heinzerling JH, Anguiano-Hernandez YM, Huerta-Yepez S, Lin J, Chen D, Bonavida B, Livingston EH.

J Surg Res. 2007 Sep;142(1):184-94. Epub 2007 Jul 2.

PMID:
17603079
2.

Smac/DIABLO and colon cancer.

Anguiano-Hernandez YM, Chartier A, Huerta S.

Anticancer Agents Med Chem. 2007 Jul;7(4):467-73. Review.

PMID:
17630921
3.

Mechanisms of resistance to TRAIL-induced apoptosis in cancer.

Zhang L, Fang B.

Cancer Gene Ther. 2005 Mar;12(3):228-37. Review.

PMID:
15550937
4.

Signaling of cell death and cell survival following focal cerebral ischemia: life and death struggle in the penumbra.

Ferrer I, Planas AM.

J Neuropathol Exp Neurol. 2003 Apr;62(4):329-39. Review.

PMID:
12722825
5.

Apoptosis-inducing factor and colon cancer.

Millan A, Huerta S.

J Surg Res. 2009 Jan;151(1):163-70. Epub 2007 Dec 3. Review.

PMID:
18061616
6.

Mutations in apoptosis genes: a pathogenetic factor for human disease.

Müllauer L, Gruber P, Sebinger D, Buch J, Wohlfart S, Chott A.

Mutat Res. 2001 Jul;488(3):211-31. Review.

PMID:
11397650
7.

Overcoming drug resistance by enhancing apoptosis of tumor cells.

Giménez-Bonafé P, Tortosa A, Pérez-Tomás R.

Curr Cancer Drug Targets. 2009 May;9(3):320-40. Review.

PMID:
19442052
8.

Regulation of apoptosis proteins in cancer cells by ubiquitin.

Zhang HG, Wang J, Yang X, Hsu HC, Mountz JD.

Oncogene. 2004 Mar 15;23(11):2009-15. Review.

PMID:
15021888
9.

Molecular targets and anticancer potential of indole-3-carbinol and its derivatives.

Aggarwal BB, Ichikawa H.

Cell Cycle. 2005 Sep;4(9):1201-15. Epub 2005 Sep 6. Review.

10.

APAF-1 signaling in human melanoma.

Anichini A, Mortarini R, Sensi M, Zanon M.

Cancer Lett. 2006 Jul 18;238(2):168-79. Epub 2005 Aug 10. Review.

PMID:
16095810
11.

Altered mechanisms of apoptosis in colon cancer: Fas resistance and counterattack in the tumor-immune conflict.

O'Connell J, Bennett MW, Nally K, Houston A, O'Sullivan GC, Shanahan F.

Ann N Y Acad Sci. 2000 Jun;910:178-92; discussion 193-5. Review.

PMID:
10911913
12.

Role of genomics-based strategies in overcoming chemotherapeutic resistance.

Kumar MV, Shirley R, Ma Y, Lewis RW.

Curr Pharm Biotechnol. 2004 Oct;5(5):471-80. Review.

PMID:
15544495
13.
14.

The modulation of inter-organelle cross-talk to control apoptosis.

Le Bras M, Rouy I, Brenner C.

Med Chem. 2006 Jan;2(1):1-12. Review.

PMID:
16787350
15.

Role of Smac/DIABLO in cancer progression.

Martinez-Ruiz G, Maldonado V, Ceballos-Cancino G, Grajeda JP, Melendez-Zajgla J.

J Exp Clin Cancer Res. 2008 Sep 26;27:48. doi: 10.1186/1756-9966-27-48. Review.

16.

Colon cancer and apoptosis.

Huerta S, Goulet EJ, Livingston EH.

Am J Surg. 2006 Apr;191(4):517-26. Review.

PMID:
16531147
17.

Apoptosis regulators.

Harada H, Grant S.

Rev Clin Exp Hematol. 2003 Jun;7(2):117-38. Review.

PMID:
14763159
18.

The inhibitors of apoptosis (IAPs) and their emerging role in cancer.

LaCasse EC, Baird S, Korneluk RG, MacKenzie AE.

Oncogene. 1998 Dec 24;17(25):3247-59. Review.

19.

Oxysterols and mechanisms of apoptotic signaling: implications in the pathology of degenerative diseases.

Lordan S, Mackrill JJ, O'Brien NM.

J Nutr Biochem. 2009 May;20(5):321-36. doi: 10.1016/j.jnutbio.2009.01.001. Review.

PMID:
19345313
20.

Caspases and cancer: mechanisms of inactivation and new treatment modalities.

Philchenkov A, Zavelevich M, Kroczak TJ, Los M.

Exp Oncol. 2004 Jun;26(2):82-97. Review.

PMID:
15273659
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk